Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-25-001112
Filing Date
2025-04-17
Accepted
2025-04-17 12:23:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 26601
2 TRANSACTIONS IN SECURITIES ex2to13da209076068_041725.htm EX-2 18235
3 TERMINATION AGREEMENT, DATED APRIL 17, 2025 ex992to13da209076068_041725.htm EX-99.2 13082
  Complete submission text file 0000921895-25-001112.txt   59391
Mailing Address 2727 KIRBY DRIVE UNIT 29L HOUSTON TX 77098
Business Address
Radoff Bradley Louis (Filed by) CIK: 0001380585 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Subject) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91836 | Film No.: 25845935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)